Loading TEVA charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading TEVA comparable companies…
| TEVATeva Pharmaceutical Industries Ltd(opens in a new tab) | $49.02B | $17.32B | +4.1% | 52.5% | 9.3% | 2.83× | 70.1× |
|---|---|---|---|---|---|---|---|
| REGNRegeneron Pharmaceuticals, Inc.(opens in a new tab) | $97.96B | $16.90B | +18.6% | 96.5% | 28.8% | 5.80× | 20.5× |
| VTRSViatris Inc(opens in a new tab) | $22.14B | $14.69B | +4.5% | 34.9% | −0.6% | 1.51× | — |
| VRTXVertex Pharmaceuticals Inc. / Ma(opens in a new tab) | $142.67B | $12.59B | +10.2% | 86.0% | 38.0% | 11.33× | 32.6× |
| BHCBausch Health Companies Inc.(opens in a new tab) | $3.13B | $11.11B | +10.8% | 71.4% | 11.2% | 0.28× | — |
| Medianpeers, excl. TEVA | $60.05B | $13.64B | +10.5% | 78.7% | 20.0% | 3.65× | 26.5× |